BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16251407)

  • 1. Susceptibility of signal transducer and activator of transcription-1-deficient mice to pulmonary fibrogenesis.
    Walters DM; Antao-Menezes A; Ingram JL; Rice AB; Nyska A; Tani Y; Kleeberger SR; Bonner JC
    Am J Pathol; 2005 Nov; 167(5):1221-9. PubMed ID: 16251407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.
    Jeong WI; Park O; Radaeva S; Gao B
    Hepatology; 2006 Dec; 44(6):1441-51. PubMed ID: 17133483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of signal transducer and activator of transcription 1 antisense oligodeoxynucleotides on inflammatory mediators, type I and type III collagen mRNA of rat pulmonary fibrosis].
    Wang WJ; Zeng M; Liu D; Fan XM; Zhu C; Zhan XQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):389-92. PubMed ID: 19426591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.
    Ebong S; Chepelinsky AB; Robinson ML; Zhao H; Yu CR; Egwuagu CE
    Mol Vis; 2004 Feb; 10():122-31. PubMed ID: 14978477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
    Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
    Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor-induced growth inhibition requires Stat1 activation.
    Bromberg JF; Fan Z; Brown C; Mendelsohn J; Darnell JE
    Cell Growth Differ; 1998 Jul; 9(7):505-12. PubMed ID: 9690618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing actions of Stat1 and Stat6 on IL-13-induced up-regulation of early growth response-1 and platelet-derived growth factor ligands in pulmonary fibroblasts.
    Ingram JL; Antao-Menezes A; Mangum JB; Lyght O; Lee PJ; Elias JA; Bonner JC
    J Immunol; 2006 Sep; 177(6):4141-8. PubMed ID: 16951379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-alpha deficiency reduces pulmonary fibrosis in transgenic mice.
    Madtes DK; Elston AL; Hackman RC; Dunn AR; Clark JG
    Am J Respir Cell Mol Biol; 1999 May; 20(5):924-34. PubMed ID: 10226062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT1-dependent and -independent pulmonary allergic and fibrogenic responses in mice after exposure to tangled versus rod-like multi-walled carbon nanotubes.
    Duke KS; Taylor-Just AJ; Ihrie MD; Shipkowski KA; Thompson EA; Dandley EC; Parsons GN; Bonner JC
    Part Fibre Toxicol; 2017 Jul; 14(1):26. PubMed ID: 28716119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma.
    Bromberg JF; Horvath CM; Wen Z; Schreiber RD; Darnell JE
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7673-8. PubMed ID: 8755534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes.
    Krejci P; Salazar L; Goodridge HS; Kashiwada TA; Schibler MJ; Jelinkova P; Thompson LM; Wilcox WR
    J Cell Sci; 2008 Feb; 121(Pt 3):272-81. PubMed ID: 18198189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of TGF-(beta) antagonism by interferon (gamma) and cyclosporine A in lung fibroblasts.
    Eickelberg O; Pansky A; Koehler E; Bihl M; Tamm M; Hildebrand P; Perruchoud AP; Kashgarian M; Roth M
    FASEB J; 2001 Mar; 15(3):797-806. PubMed ID: 11259398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway.
    Fang P; Hwa V; Rosenfeld RG
    Exp Cell Res; 2006 May; 312(8):1229-39. PubMed ID: 16427044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.
    Zhang YP; Wang WL; Liu J; Li WB; Bai LL; Yuan YD; Song SX
    Thromb Res; 2013 Jan; 131(1):64-71. PubMed ID: 23021499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
    Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
    J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes.
    Cho HJ; Kim SK; Jin SM; Hwang EM; Kim YS; Huh K; Mook-Jung I
    Glia; 2007 Feb; 55(3):253-62. PubMed ID: 17091494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cells.
    Lynch RA; Etchin J; Battle TE; Frank DA
    Cancer Res; 2007 Feb; 67(3):1254-61. PubMed ID: 17283162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotrophic tyrosine kinase receptor B/neurotrophin 4 signaling axis is perturbed in clinical and experimental pulmonary fibrosis.
    Avcuoglu S; Wygrecka M; Marsh LM; Günther A; Seeger W; Weissmann N; Fink L; Morty RE; Kwapiszewska G
    Am J Respir Cell Mol Biol; 2011 Oct; 45(4):768-80. PubMed ID: 21330466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats.
    Rice AB; Moomaw CR; Morgan DL; Bonner JC
    Am J Pathol; 1999 Jul; 155(1):213-21. PubMed ID: 10393853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.